SCHEMBL249993

SCHEMBL249993

CN(C)C1(c2cccs2)CCC(N)CC1.CN(Cc1ccccc1)C(=O)CCCC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.43
RAB9A P51151 2/20 0.43
OPRL1 P41146 6/20 0.42
OPRM1 P35372 5/20 0.42
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
FOLH1 Q04609 1/20 0.36
TACR3 P29371 1/20 0.36
AR P10275 1/20 0.36
BCHE P06276 1/20 0.35
ACHE P22303 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL249645 0.90 LMNA (0.43) NPC1RAB9AOPRL1OPRM1ALDH1A1
SCHEMBL250636 0.78 LTA4H (0.52) NPC1RAB9AKMT2AALDH1A1
SCHEMBL249977 0.77 SMN1; SMN2 (0.46) NPC1RAB9AKMT2AALDH1A1
SCHEMBL249994 0.77 NPC1 (0.45) NPC1OPRL1OPRM1KMT2ABCHE
SCHEMBL251283 0.77 OPRM1 (0.44) NPC1RAB9AOPRL1OPRM1ALDH1A1
SCHEMBL250033 0.77 OPRL1 (0.42) NPC1RAB9AOPRL1OPRM1
SCHEMBL4085419 0.77 OPRM1 (0.45) NPC1RAB9AOPRL1OPRM1ALDH1A1
SCHEMBL251309 0.76 P2RX7 (0.38) OPRL1OPRM1
SCHEMBL4074080 0.76 OPRM1 (0.51) NPC1RAB9AOPRL1OPRM1
SCHEMBL4076511 0.76 OPRL1 (0.59) OPRL1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US disclosed